However, in diabetic patients with COVID-19, the serum FGF7 concentration increased with severity (mild vs. severe: 10.28 ± 5.20 pg/ml vs. 19.70 ± 10.95 pg/ml, p = 0.0003). The gene discussed is FGF7; the disease is COVID-19.